CARGO THERAPEUTICS INC (CRGX) Stock Analyst Earnings Estimates
NASDAQ:CRGX - Nasdaq - US14179K1016 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A | N/A | N/A 2,102.11% | N/A 92.86% | N/A 51.80% | N/A 65.12% | N/A 26.78% | N/A 16.65% | ||||
| EBITDA YoY % growth | -5.96M | -34.37M -476.68% | -95.219M -177.04% | N/A -88.53% | N/A 38.64% | N/A 29.63% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -5.98M | -34.77M -481.44% | -96.71M -178.14% | N/A -94.80% | N/A 24.55% | N/A -3.49% | N/A -10.02% | N/A 33.46% | N/A 103.92% | N/A 5,872.74% | N/A 52.66% | N/A 27.10% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 83.34% | N/A 36.44% | N/A 2.47% | N/A 9.53% | N/A 31.67% | N/A 114.63% | N/A 1,804.76% | N/A 55.25% | N/A 20.21% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.98 34.21% | -0.77 11.09% | -0.58 43.00% | -0.57 35.48% | -0.57 41.91% | -0.38 51.21% | -0.34 42.11% | -0.39 31.74% | -0.37 35.52% | -0.39 -2.70% | -0.32 6.06% | -0.38 2.63% |
| Revenue Q2Q % growth | N/A | N/A | N/A | |||||||||
| EBITDA Q2Q % growth | -39.78M -18.87% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -50.851M -45.47% | -44.839M -9.88% | -35.951M 27.10% | -34.993M 25.72% | -35.873M 29.45% | -19.074M 57.46% | -20.094M 44.11% | -21.624M 38.20% | -23.256M 35.17% | N/A | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.88 98.14% | -1.15 | 0.27 | 23.75% |
| Q2 2024 Q2Q % growth | -1.02 | -1.05 | 0.03 | 2.64% |
| Q1 2024 Q2Q % growth | -0.87 | -1.07 | 0.20 | 19.02% |
| Q4 2023 Q2Q % growth | -1.49 | -1.47 | -0.02 | -1.21% |
| Q3 2023 Q2Q % growth | -47.37 | -2.84 | -44.53 | -1,568.55% |
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 2.37% | 4.6% | 0.68% | 1.57% |
| Revenue | N/A | N/A | N/A | N/A |